Archive - YXJM Finance Hub

Metaplanet Posts $605 Million Loss After Spending Billions on Bitcoin

Metaplanet Posts $605 Million Loss After Spending Billions on Bitcoin

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?

Gov. Abbott discusses launch of Texas Education Freedom Accounts program

Gov. Abbott discusses launch of Texas Education Freedom Accounts program

Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot

Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot

Former progressive makes STUNNING admission on BLM

Former progressive makes STUNNING admission on BLM

What Makes BioMarin (BMRN) so Attractive

What Makes BioMarin (BMRN) so Attractive

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

Latest

Metaplanet Posts $605 Million Loss After Spending Billions on Bitcoin

Metaplanet Posts $605 Million Loss After Spending ...

2 months ago 20

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's T...

2 months ago 18

Gov. Abbott discusses launch of Texas Education Freedom Accounts program

Gov. Abbott discusses launch of Texas Education Fr...

2 months ago 26

Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot

Real Estate Rebound? The 3X Play for Investors Bet...

2 months ago 16

Former progressive makes STUNNING admission on BLM

Former progressive makes STUNNING admission on BLM...

2 months ago 28

What Makes BioMarin (BMRN) so Attractive

What Makes BioMarin (BMRN) so Attractive

2 months ago 18

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Summit Therapeutics (SMMT) Grabs Investor Attentio...

2 months ago 15

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

FDA Guidance on MRD Negativity Bodes Well for Lege...

2 months ago 15

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (SLNO) Sparks Confidence Amid ...

2 months ago 14

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

FDA-Issued CRL for Relacorilant NDA Leads to Bulli...

2 months ago 13

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Strong Rare Disease Pipeline Drives Favorable Sent...

2 months ago 13

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Wave Life Sciences (WVE) to Benefit From Optimism ...

2 months ago 14

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Dyne Therapeutics (DYN) Attains Orphan Drug Design...

2 months ago 14

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Impressive Clinical Pipeline Leads to Bullish Sent...

2 months ago 13

Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating

Stifel Initiates Coverage on Olema Pharmaceuticals...

2 months ago 13

Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Here is Why Beam Therapeutics (BEAM) Appears so At...

2 months ago 15

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)

Guggenheim Raises Price Target for Praxis Precisio...

2 months ago 14

Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)

Orexin-2 Receptor Data Reinforces a Positive Outlo...

2 months ago 12